HS-10380

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HS-10380, covering 2023-07-28 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia [Phase 2]